Sunday, September 13, 2026

USD/CNH Is 4% Down In The Last 21 Sessions

USD/CNH Is 4% Down In The Last 21 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 4.48% for the last 21 sessions. At 19:10 EST on Wednesday, 15 March, USD/CNH (USDCNH) is $6.89.

Usd/cnh seeks support around 6.8800 as Chinese retail sales justify expectations

The USD/CNH pair is gauging a cushion around 6.8800 as China's National Bureau of Statistics (NBS) has reported flat Retail Sales (Feb) data.

USD/CNH's yearly highs and lows, it's 0.007% up from its 52-week low and 0.035% down from its 52-week high.

Previous days news about USD/CNH (USDCNH)

  • Usd/cnh price analysis: bounces off 50-dma but bears keep control. According to FXStreet on Tuesday, 14 March, "That said, the USD/CNH pair's latest recovery remains elusive unless the quote stays below the support-turned-resistance line from early February, around 6.9350 by the press time.", "It should be observed that the 7.0000 psychological magnet acts as an extra upside filter before giving control to the USD/CNH bulls."

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Chip Boom Lifts Semiconductors as Export-Control Gaps Persist
AI infrastructure demand is fueling a broad semiconductor rally — Broadcom's AI chip revenue and Q4 guidance, Amazon's custom silicon crossing a $25B annual run rate, and bullish analyst calls on Micron and Sandisk tied to a memory chip boom underestimated even by bulls — with ASML rallying on sympathy. That momentum runs alongside unresolved US-China tech tensions: Belgium's arrest of a suspect for stealing chip technology for China and a blacklisted Chinese firm still acquiring Nvidia's top AI chips show export-control enforcement lagging the pace of AI chip demand.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com